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Abstract: E. faecalis in endodontic infection represents a biofilm type of disease, which explains the bacteria’s resistance 
to various antimicrobial compounds and the subsequent failure after endodontic treatment. The purpose of this study was 
to compare antimicrobial activities and bacteria kinetic adhesion in vitro for three endodontic medicaments with a clinical 
isolate of E. faecalis. We devised a shake culture which contained the following intracanalar preparations: CPD, En-
doidrox (EIX), PulpCanalSealer (PCS); these were immersed in a liquid culture medium inoculated with the microorgan-
ism. The shake system velocity was able to prevent non-specific bacteria adhesion and simulated the salivary flow. 
Specimens were collected daily (from both the medium and medicaments) for 10 days; the viable cells were counted by 
plate count, while the adhesion index AI° [E. faecalis fg DNA] /mm
2 was evaluated in the pastes after DNA extraction, by 
quantitative real time PCR for the 16S rRNA gene. A partial growth inhibition, during the first 24 hours, was observed in 
the liquid medium and on the medicaments for EIX and subsequently for CPD (six logs). EIX showed the lowest adhesion 
coefficient (5*10
2 [fg DNA]/mm
2) for nine days and was similar to the control. PCS showed no antimicrobial/antibiofilm 
properties. This showed that “calcium oxide” base compounds could be active against biofilm progression and at least in 
the short term (2-4 days) on E. faecalis cells growing in planktonic cultures. 
INTRODUCTION  
 Enterococcus  faecalis (Streptococcus faecalis) is a facul-
tative anaerobic, Gram + cocci group D which is a member 
of the intestinal microflora [1]. It is currently isolated in a 
wide variety of human infections such as those of the urinary 
tract, the bloodstream, the abdomen, the endocardium and in 
situ foreign devices [2-5]. This organism is certainly the ma-
jor cause of failure in endodontic treatments [6,7]. It may 
cause periapical disease, perhaps due to its ability to invade 
dentinal tubes remaining viable within the tubule; in addi-
tion, it is also able to adhere to collagen and may form a 
biofilm [7]. This organism is able to adhere to several sur-
faces with different kinetics in a different manner depending 
on the clinical isolate type [8,9]; the adherence mechanism 
and subsequent biofilm formation have an important role for 
bacterial colonization and survival in the host and are impli-
cated in chronic infections [10]. In endodontic infection, E. 
faecalis first adheres to the tissue surfaces by a physical as-
sociation; in a second step there is permanent bonding by 
specific bacterial adhesins to complementary receptors on 
the host surfaces. Once the bacterial cell is bound, it is able 
to use available nutrients and a biofilm structure is necessary 
to contend with host defense mechanisms and for resistance  
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to antibacterial treatments. For these reasons, experimental 
data suggest that viable E. faecalis cells can be recovered 
from root canal systems after an effective chemo-mechanical 
instrumentation treatment [11-13]. However the coronal seal 
and the history of teeth harbouring enterococci have rarely 
been accurately investigated; a more likely recent explana-
tion for the high occurrence of enteroccci in filled root ca-
nals is that they enter during or after treatment, the origin of 
this infection is most likely food [14]. In this contest E. fae-
calis intracanalar infection can be due to salivary contamina-
tion during treatment or to inadequate root canal obturation 
by salivary microleakages [15].  
  In this work we have studied the in vitro kinetic adhesion 
of  E. faecalis in some endodontic treatments using tradi-
tional cultural methods and a novel integrated molecular 
procedure. 
  This technique consists of a particular dynamic shake 
culture system containing three different commercial intra-
canalar medicaments (see formula in material and methods): 
CPD EIX, PCS, immersed in a liquid medium and inoculated 
with the microorganism. The shake system velocity was able 
to oppose non-specific bacterial adhesion simulating the 
salivary flow in the oral cavity. The cell viability was evalu-
ated by CFU enumeration, while the adhesion capacity (AI°) 
was evaluated by quantitative real time PCR; this molecular 
technology represents the most sensitive method for recog-
nizing and quantitating bacterial DNA in a short time and  
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with high precision. Here we introduce a method for E.  
faecalis adhesion measurement by the quantization of the 
16S rRNA gene in these endodontic medicaments. 
MATERIALS AND METHODOLOGY 
Endontic Materials Used  
   Three different endodontic medicaments were used: (i) 
CPD, a recent medicament used in Italy, obtained by mixing 
three components: Stomilex (Stomigen-Rome, Italy) whose 
active principle is calcium oxide, Radiopaca iodoformic 
paste (Giovanni Ogna & Figli-Muggiò, Mi, Italy) whose 
active principles are iodoform, parachlorophenol, camphor, 
menthol and De Trey Zinc (Dentsply, De Trey-Konstanz, 
Germany); (ii) Endoidrox (EIX) whose active principle is 
calcium hydroxide; (iii) PulpCanalSealer, PCS (Kerr-USA, 
Endodontics), whose active principles are zinc oxide and 
Eugenol. 
  Each paste was made by following the manufacturer's 
recommendations and the three components of the CPD 
paste were mixed in equal parts. These compounds (using 
0.25 mg of each Endodontic treatment) did not show any 
antibacterial activity with this clinical E. faecalis strain in 48 
hours by using a conventional Kirby-Bauer diffusion method 
[16] (data not shown). 
Strain Used in this Study 
  The Enterococcus faecalis strain used was a clinical iso-
late GO2, from endodontic specimens isolated from the De-
partment of Dental Disease Prevention (University of Ca-
gliari). The bacteria were cultured in Müller Hinton agar 
(MH Microbiol, UTA, Cagliari Italy), and identified by Api 
20 Strep (bioMerieuxus Marcy l’etoile, France) [17]. A bac-
terial suspension was performed to obtain a concentration 
with a turbidity equivalent to the no. 3 McFarland standard 
(about 10
8 CFU/ml). Aliquots were stored at 70°C in 
Müller Hinton broth with 15% glycerol; this bacterial sus-
pension was used to obtain a genomic DNA standard for a 
real time quantization curve, and to inoculate shake cultures. 
Chemostat Shake Cultures 
  The dynamic culture model used (Fig. 1) [18, 19] was an 
apparatus composed as follows: 
(i)  shaking table (Continental Instruments, Italy) 
(ii)  a thermostatic 37° C chamber [Vivacar diagnostic, 
Vivadent, Italy] containing sterile flasks, Falcon 3024 
(Becton Dickinson, Meylan Cedèx, France) each with 
25 ml of Müller Hinton Broth (three flasks for each en-
dodontic compound). 
(iii) each flask contained 10  glass concave supports (ø 9 
mm) containing the same endodontic treatment (0.25 g), 
the concentration of the endodontic medicament in the 
medium per flask corresponded to 10%. 
(iv)  two flasks contained glass vials without any endodontic 
medicament (negative control samples). 
 E.  faecalis was maintained in a stationary phase for 10 
days with a title range mean of 10
7 CFU/ml by supplying the 
flask with an input of new nutrients and the daily removal of 
liquid medium, 1/3 of total volume (Fig. 1). 
  We followed the idea that salivary flow rate plays a role 
in bacterial attachment in teeth and paste surfaces (i.e. during 
intracanalar restoration) [15]. For this reason the apparatus 
constructed for this experiment was able to generate a me-
dium flow of approximately 0.5 ml/min on the medicament 
surface [20] following the subsequent formula:  
[Ø = Sp/Sf*Mvf ] 
Ø = medium flow, ml/min in each paste surface 
Sp = paste surface cm
2 
Sf = flask surface cm
2 
Mvf = medium flask volume moved in a min, ml/min 
Method for Viable Cell Count 
  Viable bacteria were counted from the chemostat liquid 
medium and from each medicament by diluting samples and 
plating the dilutions (from 10-
1 to 10-
6) on Müller Hinton 
agar. 
  Each endodontic medicament surface was washed three 
times with 5 ml of sterile 0.9% NaCl solution and success-
fully scraped by curettage following the procedure indicated 
by Teles et al. for subgingival plaque [21]. The medicament 
was suspended in Müller Hinton Broth, vortexed and used 
for CFU enumeration as described before. The viable cells 













Fig. (1). Schematic representation of the bascule culture system 
used in this work. The medium level and bacterial title (mean 10
7 
cells/ml) were both maintained by the flow rate regulator setting 
valves. 
DNA Extraction  
  Once a day for 10 days we collected three vials for each 
endodontic treatment. After four washes with nuclease-free 
H2O, the bacteria were removed from the surface by scraping 
on the medicament surface, as described previously; they 
were suspended in 400 μl of nuclease-free H2O to form a 
paste suspension. Genomic DNA was obtained by the CTAB 
modified method [22], using 400 μl of each sample (bacteria 
or paste suspension, After vigorous vortexing, 70 μl of so-
dium dodecyl sulfate (SDS) 10% and 5 μl of proteinase K 10 
mg/ml (SIGMA–Aldrich, ST. Louis Missouri USA) were 
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of NaCl 5M and 100 μl of CTAB/NaCl (0, 274 M CTAB, 
and 0, 877 M NaCl) were subsequently added, and the mix-
ture was then briefly vortexed and incubated at 65°C for 10 
minutes. 750 μl of SEVAG (Chloroform:Isoamyl Alcohol 
24:1, SIGMA) were added and the mixture was vortexed for 
10 sec. After centifugation for 5 min (at 12000 rpm) 0.6 vol-
umes of isopropanol (SIGMA) were added to the super-
natant. After 30 min at –20°C and centrifugation for 30 min 
at 12.000 rpm, the pellet was dried at room temperature for 
20 min and suspended in 15 μl of molecular biology grade 
distilled water (Gibco, Invitrogen, Paisley, Scotland, UK). E. 
faecalis genomic DNA obtained from the bacteria suspen-
sion was quantified by a RNA-DNA calculator (Pharmacia) 
and expressed as femtograms of E. faecalis DNA. 2 μl of 
this DNA suspension were used in the PCR real time reac-
tion. 
Real Time PCR  
  Real time PCR was performed using a LightCycler in-
strument and a LightCycler DNA Master SYBR Green I kit 
(Roche Diagnostics Mannheim Germany), according to the 
manufacturer’s instructions [23]. The 20 μl final volume 
contained: 4 mM MgCl2, 1 μM of each primer (OG33-
OG123) and 2 μl of DNA extract. The PCR program was the 
following: (i) denaturation at 95°C for 30 sec, (ii) 40 cycles 
of 0 sec at 95 °C, 10 sec at 50 °C, 12 sec at 72°C, (iii) melt-
ing curve performed for 0 seconds at 95°C, 45°C, 95°C. 
Transition rates were 5°C/s in the 72°C segment, 0.1 °C/s in 
the 45°C segment and 20°C/s for another step. Fluorescence 
was detected at the end of the 72°C segment in the PCR step 
(single mode), and at the 45°C segment in the melting step 
(continuous mode) in the F1 channel. During initial optimi-
zation of real time reaction, PCR products were analyzed 
using agarose gel, to ensure correct sample product size, and 
by a melting curve analysis. The positive reaction showed a 
90°C Tm peak. 
Primers for Real Time PCR  
  Primers for real time PCR were designed using the 16S 
rRNA gene sequence, extracted from the NCBI database 
GenBank with accession number AY692453. Possible oli-
gonucleotide dimer formation, self-complementarity and 
annealing temperatures of the primers were calculated using 
the Oligo program vers. 4 (MedProbe, Oslo, Norway). Real 
time PCR primers OG 33 (5’ –GACTACCAGGGTATCT- 
AATC -3’) and OG 123 (5’- AGCAGCCGCGGTAATA -3’) 
amplified a region of 286 bp. The theoretical melting tem-
peratures of these oligos (Tms) were calculated using module 
1 of the DNA hybridization prediction algorithm program 
HYTHER http://ozone3.chem.wayne.edu/ [24] with the fol-
lowing sets of parameters: (i) Monovalent cation concentra-
tion at 0.05 mol/L, (ii) Mg2+ at 0.004 mol/L, (iii) a concen-
tration of PCR products (Top/Bottom strands) at 10-
7 mol/L 
and (iv) Hybridisation temperature at 37°C. 
Expression of the E. faecalis DNA Concentration  
  A real time PCR standard curve was made on DNA ex-
tracts, obtained from different E. faecalis DNA suspensions 
with concentration ranges 10
7 -10
2 DNA fg/2 μl. The amount 
of bacterial DNA in the endodontic extracts was calculated 
by an interpolated threshold cycle with a standard curve   
(Y = -5,4X + 40,4, R
2 = 0,98) [23]. We used the following 
equation to calculate the E. faecalis adhesion index: 
AI°= ([DNA]*V°/2)/S° 
AI° is the bacterial adhesion coefficient measured in fg 
DNA /mm
2 endodontic compound surface. 
[DNA]= fg DNA in 2 μl, calculated by PCR real time 
standard curve interpolation. 
V°= volume of DNA extract suspension (15 μl during 
our experiments). S°= medicament surface (19.6 mm
2). 
RESULTS AND DISCUSSION 
  Recent hypotheses indicate that E. faecalis is introduced 
into the oral cavity in food or by operators during endodontic 
therapy. It can be spread by saliva in filled root canals during 
intracanalar treatments or by teeth lesions [14]; an associa-
tion between biofilm formation and virulence has been re-
ported for E. faecalis during dental root infection [25]. Its 
adherence to a dental surface is controlled by a number of 
variables including surface structures, nutrient availability, 
quorum sensing molecules and general fluid hydrodynamics 
[26]. Primary attachment of bacteria to a surface is mediated 
by non-specific interactions such as hydrophobic or Van der 
Wall’s forces, however with dental surfaces molecular adhe-
sions are necessary. The liquid flow normally opposes non 
specific interactions but “at the same time” can be a stimulus 
for the transition from the planktonic, free-swimming, mode 
of existence to a mature biofilm [27,28]. We have made an 
in vitro model consisting of a shake E. faecalis culture con-
taining three different endodontic medicaments. This system 
mimics an E. faecalis biofilm on endodontic sealers, and the 
medium flow/turbulence (simulating saliva in the oral cav-
ity) was an important stimulus for biofilm modulation. In 
these experiments we observed two major events in nine 
days: (i) variations in microbial growth, (ii) variations in 
mass biofilm formation on the medicament surfaces. The 
antimicrobial activity of endodontic medicaments has been 
tested using various cultural methods [29]; these studies 
were however restricted to testing of the initial activity of the 
materials and their components and were tested by the diffu-
sion Kirby Bauer method at the inhibitory concentrations. 
The concentrations used in medicaments reported in this 
work following the manufacturer’s instructions, showed no 
inhibitory effects on Müller Hinton in 48 hours with this 
clinical E. faecalis strain. However, as reported in Fig. (2), a 
good partial inhibition (six logs) within the first day, was 
observed on the MH liquid medium for CPD and EIX, with 
about 500 CFU/ml on 2*10
7 CFU in the medium without 
medicaments (control). CPS showed a 1 log max of inhibi-
tion at the first day culture and comparable results were ob-
served by viable E. faecalis cell count on medicament sur-
faces; EIX showed the lowest CFU from the first to the 
fourth day (about 500 CFU/medicament). Subsequently the 
strain showed a progressive adaptation to the pastes (from 
the fourth day on). As has also been suggested by different 
authors [30] this microorganism showed a contradictory re-
sistance profile against many endodontic medicaments, in 
particular with strains recovered in different growth phases 
or when specimens were compared; this explains the notable 
differences between different authors on comparing the same 
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model E. faecalis showed the lowest adaptability or adhesion 
propriety with EIX followed by CPD; in the present paper 
these results have also been confirmed with molecular tools. 
Fig. (3) shows the E. faecalis DNA expressed as the adhe-
sion index (AI) calculated by real time PCR with the three 
different compounds for nine culture days. This strain 
showed a different ability for biofilm formation and no bac-
terial DNA was detectable during the first hour of incubation 
(< 100 DNA copies/PCR); detection was however possible 
after 24 hours. PCS showed an increased bacterial adhesion 
during the first 48 hours with a subsequent decrease in the 
following days reaching its lowest point on the seventh day, 
after which there was a marked increase until the ninth day. 
The maximum adhesion index was reported on the ninth day: 
AI°=2.9*10
4. The adhesion of bacteria to the CPD paste re-
mained at a low level for the first 48 hours, the highest count 
of total adhering bacteria was recorded on the seventh day: 
AI°=2.7*10
3 fg of E. faecalis DNA/mm
2, (Fig. 3). EIX 
showed the lowest adhesion process, with the range and title 
between 200 and 500 fg E. faecalis DNA/mm
2 over nine 
days. In this model, cultural (viable cells) and molecular 
(AI°) methods demonstrated that medicaments containing 






















Fig. (2). Growth curves of E. faecalis in medium and in each endo-
dontic medicament reported for shake culture over nine day; each 
point represents the arithmetic mean of three determinations. The 
viable cells were expressed as colony-forming units in ml per liquid 














Fig. (3). E. faecalis adhesion kinetic curves for the three endodontic 
compounds tested in this work. Means and S.D. of at least four 
experiments are shown.The control samples were concave supports 
without endodontic medicament and only the highest values are 
represented.  
against microbial growth and against biofilm formation. This 
is in accordance with Baik et al. 2008 [33] who showed that 
calcium hydroxide activated E. faecalis lipoteichoic acid 
(LTA), considered a major virulence factor of gram-positive 
bacteria. Moreover, other authors have demonstrated that this 
substance in E. faecalis plays a positive role in biofilm for-
mation due to its alanine esters [34]. 
CONCLUSIONS  
 E.  faecalis endodontic infection represents a biofilm type 
of disease where progression of the infection and treatment 
failure are due to the high adaptability of this bacterial 
biofilm towards endodontic active compounds. This study, 
using cultural and molecular techniques, supported the the-
ory of E. faecalis’ ability to survive in these compounds; 
furthermore, it showed that calcium oxide base compounds 
could be active against biofilm progression, at least in the 
short term (2-4 days). This approach could be applied to new 
antimicrobials, as well as to "in vivo" analyses of teeth ex-
tracted after failed pulp therapy  
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